Axa S.A. Axsome Therapeutics, Inc. Transaction History

Axa S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $173,321 - $252,464	-3,100 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $348,534 - $437,784	-5,100 Reduced 62.2%	3,100 $221,000
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $408,934 - $809,258	8,200 New	8,200 $675,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.